Real-time Estimate
Cboe BZX
10:27:52 2024-05-16 am EDT
|
5-day change
|
1st Jan Change
|
5.005
USD
|
-7.66%
|
|
+6.61%
|
+1.83%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,922
|
11,678
|
14,089
|
6,662
|
2,938
|
3,254
|
-
|
-
|
Enterprise Value (EV)
1 |
16,483
|
19,993
|
24,913
|
16,694
|
12,753
|
11,106
|
10,712
|
10,409
|
P/E ratio
|
24.3
x
|
26.9
x
|
21.3
x
|
7.43
x
|
-5.28
x
|
6.78
x
|
9.87
x
|
20.2
x
|
Yield
|
4.83%
|
4.96%
|
4.74%
|
10.4%
|
17.9%
|
11.1%
|
11.1%
|
11.1%
|
Capitalization / Revenue
|
12.8
x
|
9.35
x
|
9.12
x
|
4.32
x
|
3.37
x
|
2.85
x
|
2.87
x
|
3.29
x
|
EV / Revenue
|
19.3
x
|
16
x
|
16.1
x
|
10.8
x
|
14.6
x
|
9.74
x
|
9.44
x
|
10.5
x
|
EV / EBITDA
|
22.5
x
|
18.3
x
|
18.3
x
|
12.5
x
|
18.6
x
|
11.3
x
|
11.7
x
|
12.7
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.55
x
|
1.61
x
|
1.67
x
|
0.77
x
|
0.38
x
|
0.42
x
|
0.42
x
|
0.4
x
|
Nbr of stocks (in thousands)
|
517,374
|
535,930
|
596,234
|
598,000
|
598,444
|
600,304
|
-
|
-
|
Reference price
2 |
21.11
|
21.79
|
23.63
|
11.14
|
4.910
|
5.420
|
5.420
|
5.420
|
Announcement Date
|
2/6/20
|
2/4/21
|
2/3/22
|
2/23/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
854.2
|
1,249
|
1,545
|
1,543
|
871.8
|
1,140
|
1,135
|
989.6
|
EBITDA
1 |
733.8
|
1,093
|
1,360
|
1,337
|
684.6
|
981
|
917.2
|
818.7
|
EBIT
1 |
581.5
|
828.4
|
1,039
|
1,004
|
81.28
|
644.7
|
661.1
|
633.8
|
Operating Margin
|
68.07%
|
66.32%
|
67.24%
|
65.05%
|
9.32%
|
56.54%
|
58.27%
|
64.04%
|
Earnings before Tax (EBT)
1 |
373.8
|
463.3
|
730.9
|
959.7
|
-686.8
|
518.1
|
358.3
|
310
|
Net income
1 |
374.7
|
431.4
|
656
|
902.6
|
-556.5
|
-49.07
|
329.2
|
272.1
|
Net margin
|
43.86%
|
34.54%
|
42.47%
|
58.5%
|
-63.83%
|
-4.3%
|
29.01%
|
27.49%
|
EPS
2 |
0.8700
|
0.8100
|
1.110
|
1.500
|
-0.9300
|
0.8000
|
0.5492
|
0.2686
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.020
|
1.080
|
1.120
|
1.160
|
0.8800
|
0.6000
|
0.6000
|
0.6000
|
Announcement Date
|
2/6/20
|
2/4/21
|
2/3/22
|
2/23/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
390.8
|
409.3
|
409.8
|
400.2
|
352.3
|
380.5
|
350.2
|
337.4
|
306.6
|
-122.4
|
271.3
|
300.5
|
285.7
|
279.5
|
283.9
|
EBITDA
1 |
347
|
363.2
|
359.8
|
340.2
|
306.8
|
329.9
|
301.4
|
277.1
|
262
|
-155.8
|
233.2
|
249.4
|
249.4
|
244.8
|
227.2
|
EBIT
1 |
261.9
|
279
|
274.5
|
255.9
|
224.9
|
248.4
|
217.5
|
-87.29
|
184.2
|
-233.1
|
157.6
|
176.6
|
174.7
|
174.7
|
164.9
|
Operating Margin
|
67.02%
|
68.15%
|
66.97%
|
63.94%
|
63.83%
|
65.3%
|
62.11%
|
-25.87%
|
60.08%
|
190.49%
|
58.07%
|
58.78%
|
61.15%
|
62.51%
|
58.08%
|
Earnings before Tax (EBT)
1 |
182
|
211.7
|
643.3
|
200.7
|
240.6
|
-124.9
|
36.57
|
-190.7
|
127
|
-659.6
|
-724.4
|
91.44
|
88.4
|
92.77
|
87.74
|
Net income
1 |
171.1
|
206.5
|
631.7
|
189.6
|
221.8
|
-140.5
|
32.79
|
-42.04
|
116.7
|
-663.9
|
-735.6
|
87.36
|
92.48
|
91.27
|
84.8
|
Net margin
|
43.79%
|
50.46%
|
154.14%
|
47.37%
|
62.95%
|
-36.92%
|
9.36%
|
-12.46%
|
38.07%
|
542.51%
|
-271.13%
|
29.07%
|
32.37%
|
32.66%
|
29.87%
|
EPS
2 |
0.2900
|
0.3400
|
1.050
|
0.3200
|
0.3700
|
-0.2400
|
0.2900
|
-0.0700
|
0.1900
|
-1.110
|
0.0819
|
0.1336
|
0.1523
|
0.1479
|
0.1414
|
Dividend per Share
2 |
0.2800
|
0.2800
|
0.2900
|
0.2900
|
0.2900
|
0.2900
|
0.2900
|
0.2900
|
0.1500
|
0.1500
|
0.1500
|
0.1500
|
0.1500
|
0.1500
|
0.1500
|
Announcement Date
|
10/28/21
|
2/3/22
|
4/28/22
|
8/3/22
|
10/27/22
|
2/23/23
|
4/27/23
|
8/8/23
|
10/26/23
|
2/21/24
|
5/9/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,561
|
8,316
|
10,824
|
10,033
|
9,814
|
7,852
|
7,459
|
7,156
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
7.579
x
|
7.61
x
|
7.959
x
|
7.506
x
|
14.33
x
|
8.004
x
|
8.132
x
|
8.74
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.47%
|
6.01%
|
8.32%
|
10.6%
|
-
|
2.94%
|
3.67%
|
1.97%
|
ROA (Net income/ Total Assets)
|
3.21%
|
2.76%
|
3.51%
|
4.49%
|
-
|
1.06%
|
1.77%
|
1.02%
|
Assets
1 |
11,655
|
15,648
|
18,675
|
20,089
|
-
|
-4,642
|
18,625
|
26,786
|
Book Value Per Share
2 |
13.60
|
13.60
|
14.10
|
14.40
|
12.80
|
12.80
|
13.00
|
13.70
|
Cash Flow per Share
2 |
1.150
|
1.160
|
1.380
|
1.230
|
-
|
0.8400
|
0.8100
|
0.6900
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/6/20
|
2/4/21
|
2/3/22
|
2/23/23
|
2/21/24
|
-
|
-
|
-
|
Last Close Price
5.42
USD Average target price
4.955
USD Spread / Average Target -8.58% Consensus |
1st Jan change
|
Capi.
|
---|
| +1.83% | 3.25B | | +12.53% | 60.39B | | -2.03% | 19.72B | | -0.02% | 7.6B | | -5.80% | 6.14B | | +11.26% | 3.53B | | +1.47% | 3.36B | | -2.75% | 3.3B | | +19.43% | 2.89B | | -12.11% | 2.5B |
Healthcare REITs
|